OBRR Lab

The Food and Drug Administration is issuing a forecast for a contract focused on the development of a prophylactic vaccine for visceral leishmaniasis. This initiative is managed by the OBRR Lab and falls under the NAICS code 423450, indicating a focus on medical equipment and supplies distribution. The procurement process is currently in the forecast stage, with the Cber Acquisition Liaison serving as the primary program point of contact. While a specific contracting officer has not yet been named, interested parties can find further details through the official HHS industry opportunity forecast portal.